Accendra Health Inc ACH

$0.51 -0.05 (-9.43%)

Valuation

Market cap
38,852,000
Revenue TTM
$2,762,030,000
Net income TTM
$-1,100,640,000
PE ratio
2.43
Forward PE
—
Profit margin
-39.85%
Debt to equity
-3.12

Trading

Volume
1,813,400
Avg volume
1,576,174
Day's range
$0.50 – $0.57
Shares out
76,905,000
Stochastic %K
1%
Beta
1.57
Analysts
Hold
Price target
$1.51

Price

Company profile

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure...

Show more

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Industry
Medical Distribution
Sector
Healthcare
Phone
(804) 277-4304
Website
https://www.accendrahealth.com
Address
4435 Waterfront Drive, Suite 300, Glen Allen, United States

Latest news

Stocktwits

Ld149 Oct 2, 7:03 PM
$ACH Market cap is around $39 mill now, if this breaks the 0.50s the next resistance will be 0.30s.....
0 replies
FinDic Oct 2, 6:27 PM
$ACH this thing is so cheap. Would be nice to see some BOD members purchase the stock to show some confidence in the company. The poison pill limits any activist investors taking a position and most of the institutions are stuck at their 4.9% ownership limit to avoid triggering the tax issue with that poison pill they put into place
0 replies
Winter_Haydn Oct 2, 5:17 AM
$ACH - It's hard to imagine this not pushing back up at least a little bit. Continuous red into steep territory can't go on forever. Especially with earnings at the end of this month. Company is still working on restructuring (showing progress last quarter). So definitely not worth zero yet.
1 replies
Ld149 Sep 30, 7:32 PM
$ACH on my last post i predicted this was going to 0.50 / if it does not hold the .50's it will go down to the 0.30s / DO NOT touch this stock unless you want to lose your money. They will have to do a reverse split soon to be good with NYSE guidelines. Once they do, the stock price will dropped massively again and back to < $1.00 BK is the only way out of this mess.....
0 replies
Winter_Haydn Sep 30, 4:10 PM
$ACH Is this going to bounce off of 0.50 or fall to zero? RSI is already 17.
0 replies
EnergyAlphaCo Sep 28, 10:06 PM
$ACH The new CEO-transition filing today deserves scrutiny. Ed Pesicka leaves as CEO and director on Oct. 5 but remains an advisor through March 31, 2029. There is no new salary or board authority, but his existing equity awards continue vesting. The nearly 30-month term is long, the required services are broadly defined, and the agreement does not state a conventional no-cause termination right for Accendra. His 2025 LTI grant had an $8.3M grant-date value, although the current value of the remaining awards is not disclosed and performance conditions still apply. Accendra receives transition support, a release and extended restrictive covenants. Still, this appears partly designed to preserve the departing CEO’s equity—not merely facilitate a short handoff. Our read: **negative for governance.
0 replies
FinDic Sep 25, 7:22 PM
$ACH $DJIA $IWM $QQQ $SPY Moving and grooving, vibing and sliding
0 replies
FinDic Sep 25, 5:58 PM
$SPY $DJIA $QQQ $IWM $ACH picked up some shares for a bounce. Beaten TF down. High risk, high reward
1 replies